MedPath

Correct Mobilization Time After Implantation of an Intracardiac Electronic Device Implantation

Not Applicable
Recruiting
Conditions
Defibrillators, Implantable
Pacemaker
Registration Number
NCT06330675
Lead Sponsor
Caporali Elena
Brief Summary

Bedrest is usually prescribed for patients management after cardiac electronic device implantation (CIED) in order to prevent complication. Due to the lack of guidelines available on the timing of postoperative mobilization management, the aim of the study is to evaluate the safety of early mobilization, comparing mobilization at 4-h against day-after procedure.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
558
Inclusion Criteria
  • ≥ 18 years old
  • Signed informed consent form
  • New permanent pacemaker implantation (PM) or implantable cardioverter-defibrillator (ICD)
Exclusion Criteria
  • CIED implants after recent cardiac surgery
  • Upgrade or revision of implanted device
  • CRT implantation
  • Intraoperative complications

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Composite endpoint: pacing lead dislodgement, pocket hematoma, pneumothorax, and pericardial effusionWithin 48 hours post operative

Incidence of post-operatory complications (composite endpoint). Non inferiority margin 5%

Secondary Outcome Measures
NameTimeMethod
Post-operative pain24 hours

Pain will be assessed with the Numerical Rating Scale (NRS) scale ranging from 0 to 10 (0 corresponds to no pain and 10 to maximal level of pain).

Sleep disturbanceThe first night after surgery

Quality of sleep will be assessed using the Richards-Campbell Sleep Questionnaire (RCSQ), which ranges from 0 to 500 points, where 0 indicates the worst possible sleep quality and 500 the best possible. The sub-scores include sleep depth, sleep latency, number of awakenings, return to sleep after awakening, and overall sleep quality (each ranging from 0 to 100 points).

Number of participants with postoperative urinary retentionWithin 24 hours post operative

Number of participants requiring an intervention such as a Foley catheter or catheterization

Number of participants developing postoperative deliriumWithin 24 hours post operative

Number of participants who develop postoperative delirium, as assessed by the 3-Minute Diagnostic Interview for Confusion Assessment Method (3D-CAM)

Number of participants developing orthostatic intoleranceFirst out-of-bed mobilization

Number of participants who develop symptoms of orthostatic intolerance such as dizziness, nausea, vomiting, blurred vision, or syncope, during mobilization

Quality of recoveryDay 1

Quality of recovery assessed with the Quality of recovery-15 (QoR-15) ranging from 0 (extremely poor quality of recovery) to 150 (excellent quality of recovery), and sub-scores (physical comfort 0-50, emotional state 0-40, psychological support 0-20, physical independence 0-20 and pain 0-20).

Number of participants developing pressure ulcerWithin 48 hours post operative

Number of participants who develop pressure ulcers, assessed using Pressure Ulcer Classification System (stage 1, stage 2, stage 3, and stage 4)

Trial Locations

Locations (1)

Cardiocentro Ticino Institute - EOC

🇨🇭

Lugano, Switzerland

Cardiocentro Ticino Institute - EOC
🇨🇭Lugano, Switzerland
Elena Caporali, MD
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.